We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Stresses False-Result Risk Mitigation on Dengue Virus Reagents
Guidance Stresses False-Result Risk Mitigation on Dengue Virus Reagents
Manufacturers of nucleic acid amplification test reagents for dengue virus should take a variety of steps, such as optimizing reagents and test procedures for recommended instruments, to prevent false negative or positive results, the U.S. Food and Drug Administration says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor